Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: Implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy

Scandinavian Journal of Gastroenterology

Volumn 43, Issue 9, 2008, Pages 1050-1056

  Lewerin, Catharina ^a,b   Jacobsson, Stefan ^a   Lindstedt, Göran ^a   Nilsson Ehle, Herman ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atrophic gastritis; Controlled trial; Elderly; Homocysteine; Methylmalonic acid; Vitamin B12

Indexed keywords

BACTERIUM ANTIBODY; BIOLOGICAL MARKER; CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN; HOMOCYSTEINE; IRON; METHYLMALONIC ACID; PEPSINOGEN I; PEPSINOGEN II; PYRIDOXINE;

AGED; ARTICLE; ATROPHIC GASTRITIS; CYANOCOBALAMIN DEFICIENCY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

ADMINISTRATION, ORAL; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLIC ACID; GASTRITIS, ATROPHIC; GERIATRIC ASSESSMENT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRON; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PROBABILITY; REFERENCE VALUES; REGRESSION ANALYSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITAMIN B 12; VITAMIN B 6;

EID: 49949108304     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520802078341     Document Type: Article

References (47)

1. 12) handling. Implications for therapy. Drugs Aging 1998; 12:277-92.
2. Krasinski SD, Russell RM, Samloff IM, Jacob RA, Dallal GE, McGandy RB, et al. Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators. J Am Geriatr Soc 1986;34:800-6.
3. Nilsson-Ehle H, Landahl S, Lindstedt G, Netterblad L, Stockbruegger R, Westin J, et al. Low serum cobalamin levels in a population study of 70- and 75-year-old subjects. Gastrointestinal causes and hematological effects. Dig Dis Sci 1989;34:716-23.
4. Broutet N. Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study Group. Gut 2002;50:779-85.
5. Weck MN, Brenner H. Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev 2006;15:1083-94.
6. Sande N, Nikulin M, Nilsson I, Wadström T, Laxén F, Härkönen M, et al. Increased risk of developing atrophic gastritis in patients infected with CagA+ Helicobacter pylori. Scand J Gastroenterol 2001;36:928-33.
7. Sakaki N, Kozawa H, Egawa N, Tu Y, Sanaka M. Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings. Aliment Pharmacol Ther 2002;16 Suppl 2:198-203.
8. Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996;31:546-50.
9. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-43.
10. Kokkola A, Louhimo J, Puolakkainen P, Alfthan H, Haglund C, Rautelin H. Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma. World J Gastroenterol 2005;11:1032-6.
11. Borody TJ, Andrews P, Jankiewicz E, Ferch N, Carroll M. Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori. Am J Gastroenterol 1993;88:1266-8.
12. 13C]-urea breath test, and serology. Scand J Gastroenterol 2000;35:138-41.
13. Gause-Nilsson I, Gnarpe H, Gnarpe J, Lundborg P, Steen B. Helicobacter pylori serology in elderly people: a 21-year cohort comparison in 70-year-olds and a 20-year longitudinal population study in 70-90-year-olds. Age Ageing 1998;27:433-6.
14. Kokkola A, Kosunen TU, Puolakkainen P, Sipponen P, Harkonen M, Laxen F, et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 2003;111:619-24.
15. Borch K, Axelsson CK, Halgreen H, Damkjaer Nielsen MD, Ledin T, Szesci PB. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol 1989;24:870-6.
16. Kekki M, Samloff IM, Varis K, Ihamäki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol 1991;Suppl 186:109-16.
17. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982;83:204-9.
18. Lindgren A, Lindstedt G, Kilander AF. Advantages of serum pepsinogen A combined with gastrin or pepsinogen C as first-line analytes in the evaluation of suspected cobalamin deficiency: a study in patients previously not subjected to gastrointestinal surgery. J Intern Med 1998;244:341-9.
19. 12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection. Scand J Gastroenterol 2003;38:1209-16.
20. Väänänen H, Vauhkonen M, Helske T, Kääriä inen I, Rasmussen M, Tunturi-Hihnala H, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003;15:885-91.
21. Samloff IM. Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology 1971;61:185-8.
22. Samloff IM, Liebman WM. Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology 1973;65:36-42.
23. ten Kate RW, Pals G, Eriksson AW, Donker AJ, Meuwissen SG. The renal metabolism of pepsinogen A and C in man. Clin Nephrol 1989;31:103-6.
24. Tamura H, Tokushima H, Murakawa M, Matsumura O, Itoyama S, Mitarai T, et al. Influences of Helicobacter pylori on serum pepsinogen concentrations in dialysis patients. Nephrol Dial Transplant 1999;14:113-7.
25. 12 in patients with hypochlorhydria and achlorhydria and after gastric resection. Gastroenterology 1973;64:913-9.
26. Carmel R. In vitro studies of gastric juice in patients with food-cobalamin malabsorption. Dig Dis Sci 1994;39:2516-22.
27. Laine L, Ahnen D, McClain C, Solcia E, Walsh JH. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 2000;14:651-68.
28. 12 malabsorption with antibiotics in atrophic gastritis. Gastroenterology 1991;101:1039-45.
29. Santarelli L, Gabrielli M, Cremonini F, Santoliquido A, Candelli M, Nista EC, et al. Atrophic gastritis as a cause of hyperhomocysteinaemia. Aliment Pharmacol Ther 2004;19:107-11.
30. Annibale B, Capurso G, Chistolini A, D'Ambra G, DiGiulio E, Monarca B, et al. Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms. Am J Med 2001;111:439-45.
31. Hershko C, Ronson A, Souroujon M, Maschler I, Heyd J, Patz J. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood 2006;107:1673-9.
32. DuBois S, Kearney DJ. Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence. Am J Gastroenterol 2005;100:453-9.
33. 12 and vitamin B6: a randomised trial. Eur J Clin Nutr 2003;57:1426-36.
34. Lewerin C, Ljungman S, Nilsson-Ehle H. Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly. J Intern Med 2007;261:65-73.
35. Lewerin C, Matousek M, Steen G, Johansson B, Steen B, Nilsson-Ehle H. Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study. Am J Clin Nutr 2005;81:1155-62.
36. Evans DJ, Evans DG, Graham DY, Klein PD. A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology 1989;96:1004-8.
37. Bald E, Sypniewski S. Ion-pair high-performance liquid chromatography of cysteine and metabolically related compounds in the form of their S-pyridinium derivates. J Chromatogr A 1994;676:321-30.
38. Rasmussen K. Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. Clin Chem 1989;35:260-4.
39. Solberg HE. The theory of reference values Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem 1983;21:749-60.
40. Nardone G, Rocco A, Staibano S, Mezza E, Autiero G, Compare D, et al. Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther 2005;22:1139-46.
41. Staibano S, Rocco A, Mezza E, De Rosa G, Budillon G, Nardone G. Diagnosis of chronic atrophic gastritis by morphometric image analysis. A new method to overcome the confounding effect of the inflammatory infiltrate. J Pathol 2002;198:47-54.
42. Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007;42:2-10.
43. Borch K, Jönsson KA, Petersson F, Redéen S, Mårdh S, Franzén LE. Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample: relations to symptomatology and life-style. Dig Dis Sci 2000;45:1322-9.
44. Hokkanen S, Kosunen TU, Sarna S, Miettinen A, Salomaa A, Aromaa A, et al. Normal serum pepsinogen I levels in adults: a population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies. Scand J Clin Lab Invest 2005;65:291-9.
45. Korstanje A, den Hartog G, Biemond I, Roelandse FW, Souverijn JH, Lamers CB. Role of Helicobacter pylori and autoimmunity in serological atrophic corpus gastritis in a Dutch primary care community. Eur J Gastroenterol Hepatol 2006;18:911-6.
46. 12 without intrinsic factor. Acta Med Scand 1968;184:247-58.
47. 12 (cyanokobalamin). URL: http://www.slv.se; 2004.